2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
顯示更多
執行長
Mr. William D. Baird III, M.B.A.
員工
65
國家
美國
ISIN
US9013841070
上市
0 則留言
分享你的想法
常見問題
2seventy bio 今天的股價是多少?▼
TSVT 目前價格為 $5.00 USD,過去 24 小時上漲了 +0.2%。在圖表上更密切關注 2seventy bio 股價表現。
2seventy bio 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,2seventy bio 的股票以代號 TSVT 進行交易。